These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 22353419)

  • 1. Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.
    Giannelli V; Giusto M; Farcomeni A; Ponziani FR; Pompili M; Viganò R; Iemmolo RM; Donato MF; Rendina M; Toniutto P; Pasulo L; Morelli MC; De Martin E; Miglioresi L; Di Paolo D; Fagiuoli S; Merli M;
    Transpl Int; 2012 Apr; 25(4):448-54. PubMed ID: 22353419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
    Giannini EG; Basso M; Savarino V; Picciotto A
    Aliment Pharmacol Ther; 2010 Feb; 31(4):502-8. PubMed ID: 19925499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
    Sharma P; Marrero JA; Fontana RJ; Greenson JK; Conjeevaram H; Su GL; Askari F; Sullivan P; Lok AS
    Liver Transpl; 2007 Aug; 13(8):1100-8. PubMed ID: 17377914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C.
    Pillai AA; Lee VS; Wang E; Rinella ME; Levitsky J
    Transplant Proc; 2010 Nov; 42(9):3647-51. PubMed ID: 21094833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/ribavirin.
    Miyasaka A; Kumagai I; Abe K; Suzuki K
    Hepatogastroenterology; 2012 May; 59(115):794-9. PubMed ID: 22020909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
    Dhanasekaran R; Sanchez W; Mounajjed T; Wiesner RH; Watt KD; Charlton MR
    Liver Int; 2015 Nov; 35(11):2433-41. PubMed ID: 26058570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C.
    Saab S; Oh MK; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2007 Jul; 13(7):1032-8. PubMed ID: 17600345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.
    Campos-Varela I; Esteban JI; Bes M; Caralt M; Allende H; Rodríguez-Frías F; Salcedo MT; Sauleda S; Charco R; Guardia J; Esteban R; Castells L
    J Viral Hepat; 2014 Oct; 21(10):e118-28. PubMed ID: 24620835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.
    Saab S; Greenberg A; Li E; Bau SN; Durazo F; El-Kabany M; Han S; Busuttil RW
    Liver Int; 2015 Nov; 35(11):2442-7. PubMed ID: 25913321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.
    Tanaka T; Selzner N; Therapondos G; Renner EL; Lilly LB
    Transpl Int; 2013 Jan; 26(1):42-9. PubMed ID: 23137287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved renal function in liver transplant recipients treated for hepatitis C virus with a sustained virological response and mild chronic kidney disease.
    Blé M; Aguilera V; Rubín A; García-Eliz M; Vinaixa C; Prieto M; Berenguer M
    Liver Transpl; 2014 Jan; 20(1):25-34. PubMed ID: 24115296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis C in the aged: much ado about nothing or nothing to do?
    Malnick S; Maor Y; Melzer E; Tal S
    Drugs Aging; 2014 May; 31(5):339-47. PubMed ID: 24664397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for early viral infections after liver transplantation.
    Busch CJ; Siegler BH; Werle H; Lichtenstern C; Bruckner T; Heininger A; Mehrabi A; Weiss KH; Weigand MA; Hochreiter M
    Langenbecks Arch Surg; 2018 Jun; 403(4):509-519. PubMed ID: 29696373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conceptual framework for outcomes research studies of hepatitis C: an analytical review.
    Sbarigia U; Denee TR; Turner NG; Wan GJ; Morrison A; Kaufman AS; Rice G; Dusheiko GM
    Infect Drug Resist; 2016; 9():101-17. PubMed ID: 27313473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female gender in the setting of liver transplantation.
    Rodríguez-Castro KI; De Martin E; Gambato M; Lazzaro S; Villa E; Burra P
    World J Transplant; 2014 Dec; 4(4):229-42. PubMed ID: 25540733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in liver transplantation: does sex matter?
    Sarkar M; Watt KD; Terrault N; Berenguer M
    J Hepatol; 2015 Apr; 62(4):946-55. PubMed ID: 25433162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.
    Johnston RE; Heitzeg MM
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):85-97. PubMed ID: 25313793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.